Core Insights - The report emphasizes the synergy between policy support and seasonal demand, recommending investment in high-quality leading companies in the hotel and restaurant sectors [2][3] - The performance of leading restaurant and hotel stocks has been strong, driven by service consumption policy expectations and the Spring Festival consumption peak [11][12] Market Review - In January 2026, leading stocks in the A/H/U.S. markets for chain hotels and restaurants saw significant gains, with notable performers including Jiumaojiu, Guoquan, Alibaba-W, Junting Hotel, and Guming [11][12] - Jiumaojiu led the gains, with its core brand Taier showing a continued narrowing of same-store sales decline to -3% in Q4 2025, while Guoquan forecasted a robust growth in core operating profit for 2025, expected to be around 450-470 million yuan, representing a year-on-year increase of 44.8-51.2% [2][11] Restaurant and Hotel Tracking - In December 2025, the overall restaurant revenue increased by 2.2% year-on-year, while revenue from above-limit restaurants decreased by 1.1% [14] - The CPI in December 2025 rose by 0.8% year-on-year, with service CPI increasing by 0.6%, indicating resilient growth [14] - For January 2026, the hotel industry saw a RevPAR increase of 30.7% year-on-year during the Spring Festival week, with occupancy rates (OCC) up by 8.1% and average daily rates (ADR) up by 13.5% [21] Restaurant Sector Insights - The tea beverage sector is expected to maintain single-digit year-on-year growth in January, supported by platform subsidies and product innovations [20] - The hot pot sector, particularly Haidilao, experienced a slight decline in same-store sales in January but is projected to see a recovery during the Spring Festival with an expected increase of over 5% [20] - Fast food chains like KFC and Pizza Hut are anticipated to maintain resilient growth, with expected single-digit increases in same-store sales [20] Hotel Sector Insights - The hotel sector's RevPAR showed resilient growth in January 2026, driven primarily by improvements in ADR, while occupancy rates remained stable [21][22] - Economic and mid-range hotels are performing similarly to the overall market, while high-end hotels are outperforming, although luxury hotels are showing weaker data [21][22] Investment Recommendations - The report maintains an "outperform" rating, suggesting a focus on leading service consumption companies in 2026, with key recommendations including Haidilao, Huazhu Group-S, Guming, Guoquan, Yum China, Atour, and others [3][12]

Group 1: Amer Sports Performance - Amer Sports reported a 27% year-on-year revenue growth for FY2025, reaching $6.566 billion, with an adjusted net profit of $545 million, up from $236 million in 2024 [7][8] - The fourth quarter of 2025 saw a revenue increase of 28% year-on-year to $2.101 billion, with an adjusted net profit of $176 million, compared to $90 million in Q4 2024 [8] - The management guidance for 2026 indicates a revenue growth of 16-18% at constant exchange rates, with an operating profit margin of 13.1-13.3% [8] Group 2: Silver Economy and Sports Industry - The aging population in China is creating significant opportunities in the silver economy, particularly in the sports industry and products catering to older adults [9][10] - The sports apparel market is projected to reach ¥437.7 billion by 2025, with outdoor trail running shoes expected to grow over 150% [9] - The demand for professional running shoes priced above ¥200 is anticipated to maintain double-digit growth, driven by increased health awareness among the elderly [9] Group 3: Lithium Industry Insights - The lithium market is experiencing tightening supply and low inventory levels, with global lithium demand expected to reach approximately 200,000 tons LCE in 2026 [12][14] - Domestic lithium supply is not yet at large-scale production levels, and there are potential disruptions in supply due to regulatory changes and production delays [13] - The anticipated demand from both power and energy storage batteries is expected to drive lithium prices upward, with projections suggesting prices may exceed ¥200,000 per ton in the near term [14] Group 4: Chemical Industry Policy Impact - Recent tax incentives for marine oil and gas exploration are aimed at reducing import costs for essential equipment, thereby enhancing domestic oil and gas supply capabilities [15][16] - The policy is expected to improve the internal rate of return for marine exploration projects and support the development of deep-sea oil fields [16] Group 5: Matrix Holdings Performance - Matrix Holdings is positioned as a leading high-end interior design company, with a significant recovery in profitability expected as the real estate market stabilizes [19][20] - The company anticipates a substantial increase in net profit for 2025, projected to be between ¥58 million and ¥80 million, reflecting a year-on-year growth of 72%-137% [19] - The introduction of an "AI + Design" platform is expected to enhance operational efficiency and profitability in the design process [20] Group 6: Anfu Technology's Strategic Shift - Anfu Technology has transitioned from retail to becoming a leader in the small battery sector through its acquisition of Nanfu Battery, which has shown consistent revenue growth [21][22] - The company plans to acquire the remaining shares of Nanfu Battery to enhance profitability further [22] - Anfu is also investing in high-tech sectors, including AI and semiconductor manufacturing, to diversify its business model [21][22]

Investment Rating - The report maintains an "Outperform" rating for the industry [2] Core Viewpoints - Optical Circuit Switch (OCS) technology enables direct switching of optical signals between fiber ports without optical-electrical-optical (O/E/O) conversion, significantly reducing latency and power consumption, with potential power savings of over 30% for AI computing clusters and data center interconnects [3][4][92] - The OCS market is expected to grow rapidly, with a projected market size exceeding $2.5 billion by 2029, driven by increasing demand from AI data centers and enhanced customer penetration [4][81] - The report highlights four main technology routes for OCS: MEMS, liquid crystal, piezoelectric, and silicon waveguide, with MEMS technology currently leading the market [4][14][92] Summary by Sections 1. OCS as a New Photonic Interconnect Technology - OCS technology allows for high bandwidth capabilities and low latency, making it suitable for modern data center demands [13] - The technology is transparent to rate and protocol, allowing for seamless upgrades without hardware replacement [13] - OCS can be incrementally deployed and expanded, reducing initial capital investment [13] 2. OCS Applications for AI Data Centers - Google has been at the forefront of developing ASIC chips, with the latest TPU generation utilizing OCS technology for enhanced interconnectivity [51][64] - The TPU architecture requires a significant number of ports, indicating a growing demand for OCS solutions [71] 3. OCS Industry Chain Company Layout - Various companies are positioned within the OCS industry chain, including Silex, Tengjing Technology, and Zhongji Xuchuang, each focusing on different aspects of OCS technology and components [83][84] - The report emphasizes the importance of collaboration between domestic manufacturers and leading global firms to capitalize on the OCS market growth [84] 4. Investment Recommendations - The report suggests focusing on companies within the OCS supply chain, particularly those with established partnerships with leading international firms, as they are likely to benefit from the industry's growth [4][90]

Investment Rating - The report assigns an "Outperform" rating for the company [1]. Core Insights - The company has transformed from a retail business to a leader in the domestic small battery industry by acquiring a controlling stake in Nanfu Battery and divesting its original retail operations [3][15]. - Nanfu Battery is recognized for its high profit margins, strong return on equity (ROE), and robust cash flow, maintaining a leading market share in alkaline batteries for 32 consecutive years [6][47]. - The company is actively investing in high-tech sectors, including AI and semiconductor manufacturing, to establish a second growth curve alongside its core battery business [3][5]. Summary by Sections 1. Company Overview - The company, originally established in 1984, transitioned to focus on consumer batteries after acquiring a 51% stake in Yajing Technology in 2022, thus controlling Nanfu Battery [3][15]. - It primarily produces high-performance alkaline zinc-manganese batteries, with a significant market presence in various battery types [15]. 2. Control of Nanfu Battery - The company currently holds a 46% stake in Nanfu Battery and plans to acquire the remaining shares to enhance profitability [6]. - Nanfu Battery's revenue grew from 2.18 billion to 4.64 billion from 2016 to 2024, with a compound annual growth rate (CAGR) of 10% [6][53]. 3. Strategic Investment in Yilaimi - The strategic investment in Yilaimi aims to position the company in the next-generation optical chip technology, potentially opening new growth avenues [5][6]. 4. Profit Forecast and Valuation - Revenue projections for 2025-2027 are estimated at 4.82 billion, 5.31 billion, and 5.83 billion, with corresponding net profits of 235 million, 421 million, and 594 million [6]. - The stock's fair value range is estimated between 57.6 and 69.1 yuan, corresponding to a market capitalization of 14.85 billion to 17.81 billion [6].

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical industry [2] Core Insights - 2025 saw a record high in innovative drug asset transactions among multinational pharmaceutical companies, with 142 cases and a total transaction value of $264.5 billion, marking new highs since 2015 [3][9] - Eli Lilly's revenue for 2025 increased by 44% year-on-year, driven by GLP-1 drugs, with Tirzepatide achieving $36.5 billion in sales [3][39] - Novo Nordisk's sales growth was impacted by increased competition in the weight loss drug market, with a projected revenue decline of 5% to 13% for 2026 [3][40] Summary by Sections 1. Innovative Drug Asset Transactions - In 2025, the number of innovative drug transactions reached 142, with mergers and acquisitions (M&A) and collaborations at 36 and 106 respectively, both setting new records since 2015 [3][9] - The total transaction value was $264.5 billion, with M&A accounting for $106 billion and collaborations for $158.4 billion, also new highs since 2015 [3][9] 2. Performance Review of Pharmaceutical Companies - Eli Lilly's total revenue for 2025 was $65.2 billion, with a guidance for 2026 revenue between $80 billion and $83 billion, indicating a projected growth of 25% [3][39] - Novo Nordisk's total revenue for 2025 was 309.1 billion Danish Kroner, with a guidance for 2026 indicating a decline of 5% to 13% [3][40] - Other companies like AbbVie, AstraZeneca, and Roche reported single-digit growth, while JNJ and Gilead faced challenges due to patent expirations [3] 3. Factors Influencing M&A Decisions - Demand for acquisitions is driven by the need to address revenue gaps from expiring patents and declining R&D efficiency [3][19] - Financial capacity for M&A is supported by free cash flow after shareholder returns, allowing for smaller acquisitions [3][20] - Pricing considerations are crucial, as the valuation of innovative drug assets significantly impacts the internal rate of return (IRR) for acquisitions [3][21]

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical industry [2] Core Insights - 2025 saw a record high in innovative drug asset transactions among multinational pharmaceutical companies, with 142 cases and a total transaction value of $264.5 billion, marking new highs since 2015 [3][9] - Eli Lilly's revenue for 2025 increased by 44% year-on-year, driven by GLP-1 drugs, with Tirzepatide achieving $36.5 billion in sales [3][39] - Novo Nordisk's sales growth was impacted by increased competition in the weight loss drug market, with a projected revenue decline of 5% to 13% for 2026 [3][40] Summary by Sections 1. Innovative Drug Asset Transactions - In 2025, the number of innovative drug transactions reached 142, with mergers and acquisitions (M&A) and collaborations at 36 and 106 respectively, both setting new records since 2015 [3][9] - The total transaction value was $264.5 billion, with M&A accounting for $106 billion and collaborations for $158.4 billion, also new highs since 2015 [3][9] 2. Performance Review of Pharmaceutical Companies - Eli Lilly's total revenue for 2025 was $65.2 billion, with a guidance of $80 billion to $83 billion for 2026, indicating a projected growth of 25% [3][39] - Novo Nordisk's revenue for 2025 was 309.1 billion Danish Krone, with a guidance for 2026 indicating a decline of 5% to 13% [3][40] - Other companies like AbbVie, AstraZeneca, and Roche reported single-digit growth, while JNJ and Gilead faced challenges due to patent expirations [3] 3. Factors Influencing M&A Decisions - Demand for acquisitions is driven by the need to address revenue gaps from expiring patents and declining R&D efficiency [3][19] - Financial capacity for M&A is supported by free cash flow after shareholder returns, allowing for smaller acquisitions [3][20] - Pricing considerations are crucial, as the valuation of innovative drug assets significantly impacts the internal rate of return (IRR) for acquisitions [3][21]

Core Insights - The report highlights a positive outlook for various industries in March 2026, driven by domestic demand policies and sector-specific growth opportunities [2][3] - Key stocks recommended across different sectors are expected to show significant profit growth and favorable valuations, indicating potential investment opportunities [2][3] Industry Summaries Social Services - China Oriental Education is positioned to benefit from the growth in new service consumption, with a projected net profit of 1.1 billion yuan in 2026, reflecting a 40% increase and a PE ratio of approximately 11 times [2][3] Construction - Yaxin Integration is expected to gain from significant investments in the cleanroom industry, with orders and performance not fully anticipated, particularly from major clients like Micron and TSMC [2][3] Non-Bank Financials - CITIC Securities is recommended as a leading brokerage benefiting from market recovery and favorable policy environments, with valuations not reflecting the improving profit trends [2][3] Agriculture - Youran Dairy, a leader in dairy farming, is set to benefit from rising beef and milk prices, with expectations of high earnings recovery due to favorable market conditions [2][3] Power Equipment and New Energy - Delijia is expanding its capacity in wind power gearbox projects, with a strong order backlog and projected profit growth of 55% in 2025 [2][3] - Sifang Co. is actively expanding its overseas presence and has secured multiple projects, with a focus on cutting-edge technologies like solid-state transformers [2][3] Automotive - Xingyu Co. is positioned in a high-growth segment of automotive lighting, with a focus on smart products and expanding its global customer base, projecting revenues of 16 billion yuan in 2025 [2][3] Home Appliances - Haier Smart Home is benefiting from domestic policies promoting appliance upgrades and is enhancing operational efficiency through digital transformation, with a stable increase in market share [2][3] Basic Chemicals - Chuanheng Co. is expected to increase its phosphate mining capacity significantly by 2028, with a strong dividend payout history and high-quality product offerings [2][3] Military Industry - Lianchuang Optoelectronics is experiencing substantial growth in laser products and is entering the commercial space launch market, indicating a broad market potential [2][3]

Investment Rating - The report maintains an "Outperform" rating for the industry [2] Core Viewpoints - Optical Circuit Switch (OCS) technology enables direct switching of optical signals between fiber ports without optical-electrical-optical (O/E/O) conversion, significantly reducing latency and power consumption, with potential power savings of over 30% for AI computing clusters and data center interconnect systems [3][4][92] - The OCS market is expected to grow rapidly, with a projected market size exceeding $2.5 billion by 2029, driven by increasing demand for AI data centers and enhanced customer penetration [4][79] - OCS technology has four main technical routes: MEMS, liquid crystal, piezoelectric, and silicon waveguide, with MEMS being the fastest to commercialize, primarily led by Google [4][14][92] Summary by Sections 1. OCS as a New Photonic Interconnect Technology - OCS technology avoids traditional bandwidth bottlenecks and power losses associated with electrical switching, offering high bandwidth capacity and low latency [3][13] - The four main technical routes for OCS are MEMS, liquid crystal, piezoelectric, and silicon waveguide, each with different cost, performance, and technical difficulty trade-offs [14][92] 2. OCS Applications for AI Data Centers - Google has been at the forefront of developing ASIC chips, with the TPU reaching its seventh generation, indicating a strong push towards integrating OCS technology in data centers [51][64] - The TPU architecture utilizes OCS technology to interconnect thousands of TPU chips, enhancing performance and efficiency [64][71] 3. OCS Industry Chain Company Layout - Various companies are positioned within the OCS industry chain, including Silex, Tengjing Technology, and Zhongji Xuchuang, each focusing on different aspects of OCS technology and components [83][84] - Companies like Lumentum and Coherent are key suppliers for MEMS and liquid crystal OCS solutions, indicating a robust supply chain for OCS technology [4][14][84] 4. Investment Recommendations - The report suggests focusing on companies within the OCS supply chain, particularly those with deep collaborations with leading global firms, such as Zhongji Xuchuang and Guangxun Technology, as they are expected to benefit from the growth in OCS technology [4][90]

Investment Rating - The investment rating for the industry is "Outperform the Market" (maintained) [3][26]. Core Insights - The report highlights the support of tax incentives for marine oil and gas development and natural gas import utilization, aiming to enhance domestic oil and gas supply capabilities and ensure national energy security [4][5]. - The report emphasizes the increasing importance of imported natural gas in China's energy supply, with a focus on stabilizing costs through tax refunds on eligible imports [5][14]. - The marine oil and gas sector is identified as a strategic focus for future development, with significant investments expected to continue in the coming years [6][9]. Summary by Sections Industry Policy Commentary - The Ministry of Finance, Customs, and the State Taxation Administration issued a notification on tax incentives for energy resource exploration and development during the 14th Five-Year Plan period, including exemptions on import duties for essential equipment used in marine oil and gas exploration [4]. - The policy aims to reduce the import costs of marine oil and gas exploration equipment, thereby enhancing project internal rates of return and promoting deep-sea oil and gas field development [5][22]. Market Trends - Global marine oil and gas exploration spending has been on the rise, with investments exceeding $100 billion in 2022 and expected to remain high in the coming years [6]. - China's marine oil and gas exploration and production expenditures are projected to continue increasing, with CNOOC's capital expenditure for 2024 estimated at 132.7 billion yuan, reflecting a growth trend [9]. Investment Recommendations - The report suggests focusing on companies such as CNOOC, CNOOC Services, and CNOOC Development due to the favorable tax policies that will lower equipment procurement costs and enhance project profitability [5][22]. - It also recommends monitoring China National Petroleum Corporation (CNPC) and CNOOC in light of the tax refund mechanism for imported natural gas, which is expected to mitigate cost fluctuations, especially during high gas price periods [5][22].

Investment Rating - The investment rating for the company is "Outperform the Market" [1] Core Insights - The company, Anfu Technology, has transformed from a retail business to a leader in the domestic small battery industry by acquiring a controlling stake in Nanfu Battery and divesting its original retail operations [3][15] - Nanfu Battery is recognized for its high profit margins, strong return on equity (ROE), and robust cash flow, maintaining a market share of over 80% in the domestic alkaline battery market [6][47] - The company is actively investing in high-tech sectors, including AI and semiconductor manufacturing, to build a second growth curve alongside its core battery business [3][5] Summary by Sections 1. Anfu Technology: Domestic Small Battery Industry Leader - Anfu Technology was established in 1984 and listed on the A-share market in 2016, initially focusing on retail [15] - In 2022, the company acquired 51% of Yajing Technology, gaining control of Nanfu Battery and successfully transitioning to the consumer battery sector [15][12] 2. Controlling Nanfu Battery: A Stable "Cash Cow" Business - Nanfu Battery has been the market leader in alkaline manganese batteries for 32 consecutive years, with a retail market share of 85.9% in alkaline 5 and 7 batteries for 2024 [6][47] - Revenue for Nanfu Battery grew from 2.18 billion to 4.64 billion (CAGR +10%) from 2016 to 2024, with net profit increasing from 500 million to 920 million (CAGR +8%) [6][53] - The company plans to acquire the remaining shares of Yajing Technology and minority stakes in Nanfu Battery to enhance profitability [6] 3. Strategic Investment in Yilaimi: Potential for "Electric + Optical" Dual Layout - Yilaimi is positioned to develop next-generation optical chips, with a production capacity supporting 200,000 to 500,000 chips annually [6] - The strategic investment in Yilaimi is part of the company's broader strategy to integrate into the semiconductor industry and explore new growth avenues [6] 4. Profit Forecast and Valuation - Revenue projections for 2025-2027 are 4.82 billion, 5.31 billion, and 5.83 billion, with year-on-year growth rates of +4.0%, +10.1%, and +9.8% respectively [6] - The estimated net profit attributable to the parent company for the same period is 235 million, 421 million, and 594 million, reflecting significant growth [6] - The stock's reasonable value range is estimated between 57.6 and 69.1 yuan, corresponding to a market capitalization of 14.85 billion to 17.81 billion [6]